| abstract |
There are disclosed compound of Formula (I) or (II) or a harmaceutically acceptable salt thereof, in the manufacture of a medicament for the therapeutic and/or prophylactic treatment of Duchenne muscular dystrophy, Becker muscular dystrophy or cachexia. Wherein A<1>, A<2>, A<3>, A<4>and A<5>, which may be the same or different, represent N or CR<1>, R9 represents - L -R<3>, in which L is a single bond or a linker group and R<3> represents hydrogen or a substituent and in addition, when an adjacent pair of A<1> - A<4> each represent CR<1>, then the adjacent carbon atoms, together with their substituents may form a ring B, when A<5> represents CR<1>, then A<5> and N - R<9>, together with their substituents may form a ring C. |